Physician profile
Michael N Polinsky
NPI 1134183205
$1,196.43
in general payments reported to CMS, 2019-2025
11 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.17 · 2020: $194 · 2022: $117 · 2023: $489 · 2024: $172 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $303.53 | 2023-2024 | |
| Zap Surgical Systems, INC. | $193.56 | 2020 | |
| Zimvie INC. | $138.56 | 2023 | |
| Janssen Biotech, INC. | $135.65 | 2025 | Carvykti, Rybrevant |
| Olympus America INC. | $129.39 | 2023 | Itind System |
| Corelink, LLC | $100.00 | 2022 | |
| Integra Lifesciences Corporation | $82.30 | 2019-2022 | |
| Abbott Laboratories | $48.75 | 2023-2025 | Infinity, Eterna |
| Baxter Healthcare | $29.05 | 2024 | Floseal |
| Medtronic, INC. | $20.16 | 2024 | Kyphon Express II Kyphopak Tray |
| Astrazeneca Pharmaceuticals LP | $15.48 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Polinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.